Results 11 to 20 of about 373,840 (223)
Blood, 2019 Prior studies have reported high response rates with recombinant interferon-α (rIFN-α) therapy in patients with essential thrombocythemia (ET) and polycythemia vera (PV).
Yacoub A +33 more
europepmc +2 more sources
Interferon-alpha induced obsessivecompulsive disorder in a patient with Hepatitis-C
Psychiatry and Clinical Psychopharmacology, 2021 Interferon alpha (IFN- α) is commonly used in the treatment of viral hepatitis because of its stimulating effects on the immune response. While psychiatric adverse effects such as depression, mania or psychosis that arise during interferon alpha ...
Selma Bozkurt Zincir +3 more
doaj +1 more source
Economic evaluation of first-line treatments for metastatic renal cell carcinoma: a cost-effectiveness analysis in a health resource-limited setting. [PDF]
PLoS ONE, 2012 BACKGROUND: To estimate, from the perspective of the Chinese healthcare system, the economic outcomes of five different first-line strategies among patients with metastatic renal cell carcinoma (mRCC).
Bin Wu +6 more
doaj +1 more source
Interferon-alfa in the management of cystic craniopharyngioma in children under 5 years of age
Archives of Pediatric Neurosurgery, 2021 Introduction: the best therapeutic option for the management of craniopharyngioma in younger children remains controversial, ranging from complete surgical resection, partial surgical resection associated with radiotherapy and application of ...
Jose Roberto Tude Melo +3 more
doaj +1 more source
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
Hepatology, EarlyView., 2022 Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr +19 more
wiley +1 more source
Importance of adherence for efficacy of hepatitis C combined therapy [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2013 Introduction. Dual antiviral therapy with pegylated interferon alfa-2a and ribavirin leads do sustained elimination of hepatitis C virus infection in over 50% patients with genotypes 1 and 4 and in over 80% with genotypes 2 and 3.
Nožić Darko +5 more
doaj +1 more source
JGH Open, 2022 Background and Aim Ropeginterferon alfa‐2b is a novel mono‐pegylated, extra‐long‐acting interferon. It is administered infrequently and showed good tolerability and clinical activity for the chronic hepatitis B or C treatment in our previous Phase 2 ...
Chi‐Yi Chen +22 more
doaj +1 more source